Filing Details
- Accession Number:
- 0001127602-16-045954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-10 17:21:26
- Reporting Period:
- 2016-03-09
- Filing Date:
- 2016-03-10
- Accepted Time:
- 2016-03-10 17:21:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536574 | W Gregory Matz | 6140 Stoneridge Mall Road, Suite 590 Pleasanton CA 94588 | Svp, Cfo & Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-09 | 10,000 | $38.89 | 25,123 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-09 | 1,800 | $144.93 | 23,323 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-09 | 1,600 | $145.82 | 21,723 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-09 | 4,700 | $147.21 | 17,023 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-09 | 1,800 | $147.91 | 15,223 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-09 | 100 | $148.81 | 15,123 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2016-03-09 | 10,000 | $0.00 | 10,000 | $38.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,750 | 2020-05-02 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a 10b5-1 plan adopted 7/14/14.
- The price represents an average of sale prices between $144.39 and $145.36.
- The price represents an average of sale prices between $145.49 and $146.46.
- The price represents an average of sale prices between $146.63 and $147.62.
- The price represents an average of sale prices between $147.63 and $148.62.
- 5/3/2010 NQ Grant: The options will vest in equal increments over four years measured from the date of grant as follows: 1/4 shall vest on 5/3/2011; 1/4 shall vest on 5/3/2012; 1/4 shall vest on 5/3/2013; and 1/4 shall vest on 5/3/2014.
Billionaire Hedge Funds
